A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

Expanding serotype coverage of pneumococcal conjugate vaccines (PCVs) to target prevailing disease-causing serotypes could further reduce disease burden. To address this need, 2 different PCVs have been investigated: a 20-valent PCV (PCV20; includes the 13 serotypes in the 13-valent PCV [PCV13] plus...

全面介紹

書目詳細資料

Principais autores:	David Fitz-Patrick, Mariano Young Jr, Daniel A. Scott, Ingrid L. Scully, Gary Baugher, Yahong Peng, Kathrin U. Jansen, William Gruber, Wendy Watson
格式:	Artigo
語言:	Inglês
出版:	Taylor & Francis Group 2021-07-01
叢編:	Human Vaccines & Immunotherapeutics
主題:	streptococcus pneumoniae clinical trial pneumococcal conjugate vaccine immunogenicity safety pcv20 cpcv7
在線閱讀:	http://dx.doi.org/10.1080/21645515.2020.1863177
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!